Intravascular Imaging Evaluated Calcified Nodule China Registry
NCT ID: NCT07262359
Last Updated: 2025-12-03
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
NOT_YET_RECRUITING
Total Enrollment
500 participants
Study Classification
OBSERVATIONAL
Study Start Date
2025-12-01
Study Completion Date
2031-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
What is this study about? This is a nationwide research study in China focused on understanding a specific type of challenging plaque in heart arteries called a Calcified Nodule (CN). The study will use advanced imaging technology inside the blood vessels to see these nodules in great detail, track how they are treated, and see how patients do in the long term.
Why is this important? Calcified nodules are hard, bony-like plaques that can cause sudden heart attacks. They are difficult to treat with standard procedures like stenting because they are rigid and can be unpredictable. This registry aims to create a large database of real-world cases to help doctors better understand how to identify and manage CNs effectively, ultimately improving patient care and outcomes across China.
What are IVUS and OCT? These are sophisticated imaging tools that doctors use during a heart catheterization. Think of them like a "GPS" or an "ultrasound" for the inside of your arteries.
IVUS (Intravascular Ultrasound): Uses sound waves to create a detailed, 360-degree picture of the artery wall. It shows the size of the plaque and how deep it goes, helping doctors choose the right size stent.
OCT (Optical Coherence Tomography): Uses light waves to create extremely high-resolution images, like a microscope inside the artery. It is excellent for seeing the precise surface and structure of a calcified nodule.
Together, these tools give doctors a clear view of the problem, which is crucial for planning the best treatment strategy.
What will the study do?
The registry will collect anonymous data from participating hospitals across China. Researchers will analyze:
How common calcified nodules are in Chinese patients.
The best ways to use IVUS and OCT to identify and characterize CNs.
Which treatment techniques (e.g., special balloons, atherectomy) work best.
The long-term results for patients who receive stents to treat a CN.
Who is this for?
Patients \& Families: To understand that advanced care and research are being dedicated to complex heart conditions. Participation (if eligible) contributes to medical knowledge that may help future patients.
Healthcare Providers: To provide a standardized, large-scale analysis of CNs, leading to improved diagnosis, treatment guidelines, and procedural techniques for this complex lesion.
This registry represents a significant step forward in personalized cardiac care in China, using cutting-edge technology to solve a difficult clinical problem.
Why is this important? Calcified nodules are hard, bony-like plaques that can cause sudden heart attacks. They are difficult to treat with standard procedures like stenting because they are rigid and can be unpredictable. This registry aims to create a large database of real-world cases to help doctors better understand how to identify and manage CNs effectively, ultimately improving patient care and outcomes across China.
What are IVUS and OCT? These are sophisticated imaging tools that doctors use during a heart catheterization. Think of them like a "GPS" or an "ultrasound" for the inside of your arteries.
IVUS (Intravascular Ultrasound): Uses sound waves to create a detailed, 360-degree picture of the artery wall. It shows the size of the plaque and how deep it goes, helping doctors choose the right size stent.
OCT (Optical Coherence Tomography): Uses light waves to create extremely high-resolution images, like a microscope inside the artery. It is excellent for seeing the precise surface and structure of a calcified nodule.
Together, these tools give doctors a clear view of the problem, which is crucial for planning the best treatment strategy.
What will the study do?
The registry will collect anonymous data from participating hospitals across China. Researchers will analyze:
How common calcified nodules are in Chinese patients.
The best ways to use IVUS and OCT to identify and characterize CNs.
Which treatment techniques (e.g., special balloons, atherectomy) work best.
The long-term results for patients who receive stents to treat a CN.
Who is this for?
Patients \& Families: To understand that advanced care and research are being dedicated to complex heart conditions. Participation (if eligible) contributes to medical knowledge that may help future patients.
Healthcare Providers: To provide a standardized, large-scale analysis of CNs, leading to improved diagnosis, treatment guidelines, and procedural techniques for this complex lesion.
This registry represents a significant step forward in personalized cardiac care in China, using cutting-edge technology to solve a difficult clinical problem.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Coronary Atherosclerosis Disease Early Identification and Risk Stratification by Noninvasive Imaging
NCT03518437
Coronary Artery Disease
UNKNOWN
National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
NCT05437965
Coronary Artery Disease
Arteritis
In-Stent Stenosis (Restenosis) of Coronary Artery Stent
RECRUITING
Precision Therapy in Complex High-risk Coronary Artery Disease
NCT04444960
Coronary Artery Disease
UNKNOWN
CRUSTAL Study in China
NCT05828186
Coronary Artery Disease
Calcification
ACTIVE_NOT_RECRUITING
Identification Of High-risk Coronary Plaques By Multimodal Intravascular Imaging
NCT06681155
Coronary Arterial Disease (CAD)
Acute Coronary Syndromes
NOT_YET_RECRUITING
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Study Title and Overview
Official Title: A Multi-Center, Prospective, Observational Registry for the Evaluation of Coronary Artery Calcified Nodules Using Intravascular Ultrasound (IVUS) and/or Optical Coherence Tomography (OCT) in China (CN-IVI Registry)
Overview: The CN-IVI Registry is a large-scale, observational study conducted across multiple leading cardiac centers in China. Its primary purpose is to systematically investigate a specific, complex, and high-risk type of coronary plaque known as a Calcified Nodule (CN). By leveraging advanced intracoronary imaging techniques, IVUS and/or OCT, the registry aims to create a robust database to improve the diagnosis, characterization, treatment, and long-term outcomes for patients with this challenging lesion.
2. Background and Rationale: Why Focus on Calcified Nodules?
Coronary artery disease (CAD) involves the buildup of plaque inside the heart's arteries. While there are several types of plaque, Calcified Nodules are among the most complex and dangerous.
What is a Calcified Nodule? A CN is a specific type of plaque characterized by a sharp, protruding, and often fractured nodule of calcium that erupts through the artery's inner lining (intima). This creates a irregular, bony surface within the blood vessel that is highly thrombogenic (likely to cause blood clots) and is a known cause of sudden acute coronary syndromes (heart attacks).
The Clinical Challenge: Treating CNs with percutaneous coronary intervention (PCI) - the procedure to open blocked arteries and place stents - is notoriously difficult. Their hard, irregular nature makes it challenging to fully expand a stent. Incomplete stent expansion, known as "stent underexpansion," is a leading cause of stent failure, including restenosis (re-narrowing) and stent thrombosis (a dangerous blood clot within the stent).
The Role of Intravascular Imaging: Angiography, the standard X-ray technique used during PCI, is a "shadow" of the artery's interior and often fails to accurately depict the complexity of a CN. This is where IVUS and OCT become critical. They act like a high-definition camera and ultrasound inside the artery, allowing interventional cardiologists to:
Accurately Identify a calcified nodule versus other types of plaque.
Characterize its size, shape, and extent of calcium.
Plan the Procedure by choosing the best techniques to modify the calcium (e.g., with high-pressure balloons, scoring balloons, or rotational atherectomy).
Optimize the Result by ensuring the stent is fully expanded and well-apposed to the vessel wall after implantation.
Despite their importance, there is a lack of large-scale, real-world data on the prevalence, optimal management, and outcomes of CNs in the Chinese population. This registry seeks to fill that critical knowledge gap.
3. Primary and Secondary Objectives
The CN-IVI Registry is designed to answer several key questions:
Primary Objectives:
To determine the prevalence and natural distribution of calcified nodules in a large, real-world Chinese cohort of patients undergoing PCI with intravascular imaging guidance.
To establish the diagnostic criteria and imaging characteristics of CNs using both IVUS and/or OCT, creating a standardized definition for Chinese patients.
Secondary Objectives:
To evaluate the immediate procedural success rates of PCI for lesions containing CNs, as assessed by intravascular imaging (e.g., rate of stent underexpansion, acute stent malapposition).
To assess the impact of different calcium modification techniques (e.g., non-compliant balloons, scoring/cutting balloons, rotational/orbital atherectomy, intravascular lithotripsy) on the final stent result.
To investigate the long-term clinical outcomes for patients with CNs, including:
Target Lesion Failure (TLF): A composite of cardiac death, target vessel myocardial infarction, and clinically-driven target lesion revascularization (need for a repeat procedure).
Rates of stent thrombosis.
4. Study Design and Methodology
Type: Prospective, multi-center, observational registry.
Participants: Adult patients (≥18 years) undergoing coronary angiography and PCI for stable coronary artery disease or acute coronary syndromes at participating centers in China, in whom the use of IVUS or OCT is clinically indicated and identifies the presence of a calcified nodule.
Data Collection: All clinical, procedural, and imaging data will be collected prospectively in a centralized, secure electronic database. This includes:
Patient demographics and cardiovascular risk factors.
Angiographic data of the target lesion.
Raw IVUS and OCT imaging sequences, which will be analyzed in a dedicated core lab by independent experts blinded to patient outcomes to ensure consistency and objectivity.
Detailed procedural data, including devices used and complications.
Follow-up: Patients will be followed clinically for up to 3 years after the procedure through outpatient visits and telephone interviews to track their long-term health status and any cardiac-related events.
5. What Participation Means
For Patients: Participation in this registry does not change your standard medical care. The procedures (angiography, PCI, IVUS/OCT) are all performed based on your clinical need and your doctor's judgment. The registry simply involves allowing researchers to anonymously collect and analyze the data and images from your procedure for the purposes of this study. Your personal information will be kept strictly confidential. Your involvement will help advance medical knowledge and improve care for future patients with similar conditions.
For Families: This research aims to improve the safety and effectiveness of heart procedures for a particularly tricky problem. By supporting your family member's participation, you are contributing to a national effort to establish best practices that could benefit countless others.
For Healthcare Providers: This registry will provide invaluable, real-world evidence. It will offer deep insights into the imaging phenotypes of CNs, serve as a benchmark for procedural outcomes, and help generate data-driven guidelines for managing these complex lesions. The core lab analysis will also be an educational resource for the interventional cardiology community.
6. Potential Significance and Impact
The findings from the CN-IVI Registry are expected to have a direct impact on clinical practice:
Improved Diagnosis: Establish clear, imaging-based criteria for identifying CNs in Chinese patients.
Better Treatment Strategies: Provide evidence for which calcium modification techniques are most effective for preparing a nodule for stenting, leading to higher procedural success rates.
Enhanced Patient Safety: By optimizing stent implantation, the study aims to reduce long-term complications like stent failure and heart attacks, improving overall patient prognosis.
National Guidelines: The data will inform the development of Chinese and international clinical guidelines on the management of heavily calcified coronary lesions.
7. Ethics and Confidentiality
The study will be conducted in full compliance with the Declaration of Helsinki and Chinese regulatory requirements. The protocol will be approved by the Institutional Review Board (IRB) or Ethics Committee at each participating center. Written informed consent will be obtained from every patient before their data is included in the registry. All patient data will be de-identified to ensure absolute privacy and confidentiality.
In summary, the CN-IVI Registry represents a major collaborative effort to tackle a complex problem in interventional cardiology. By harnessing the power of intravascular imaging, it seeks to translate detailed visual data into tangible improvements in patient care and outcomes across China.
Official Title: A Multi-Center, Prospective, Observational Registry for the Evaluation of Coronary Artery Calcified Nodules Using Intravascular Ultrasound (IVUS) and/or Optical Coherence Tomography (OCT) in China (CN-IVI Registry)
Overview: The CN-IVI Registry is a large-scale, observational study conducted across multiple leading cardiac centers in China. Its primary purpose is to systematically investigate a specific, complex, and high-risk type of coronary plaque known as a Calcified Nodule (CN). By leveraging advanced intracoronary imaging techniques, IVUS and/or OCT, the registry aims to create a robust database to improve the diagnosis, characterization, treatment, and long-term outcomes for patients with this challenging lesion.
2. Background and Rationale: Why Focus on Calcified Nodules?
Coronary artery disease (CAD) involves the buildup of plaque inside the heart's arteries. While there are several types of plaque, Calcified Nodules are among the most complex and dangerous.
What is a Calcified Nodule? A CN is a specific type of plaque characterized by a sharp, protruding, and often fractured nodule of calcium that erupts through the artery's inner lining (intima). This creates a irregular, bony surface within the blood vessel that is highly thrombogenic (likely to cause blood clots) and is a known cause of sudden acute coronary syndromes (heart attacks).
The Clinical Challenge: Treating CNs with percutaneous coronary intervention (PCI) - the procedure to open blocked arteries and place stents - is notoriously difficult. Their hard, irregular nature makes it challenging to fully expand a stent. Incomplete stent expansion, known as "stent underexpansion," is a leading cause of stent failure, including restenosis (re-narrowing) and stent thrombosis (a dangerous blood clot within the stent).
The Role of Intravascular Imaging: Angiography, the standard X-ray technique used during PCI, is a "shadow" of the artery's interior and often fails to accurately depict the complexity of a CN. This is where IVUS and OCT become critical. They act like a high-definition camera and ultrasound inside the artery, allowing interventional cardiologists to:
Accurately Identify a calcified nodule versus other types of plaque.
Characterize its size, shape, and extent of calcium.
Plan the Procedure by choosing the best techniques to modify the calcium (e.g., with high-pressure balloons, scoring balloons, or rotational atherectomy).
Optimize the Result by ensuring the stent is fully expanded and well-apposed to the vessel wall after implantation.
Despite their importance, there is a lack of large-scale, real-world data on the prevalence, optimal management, and outcomes of CNs in the Chinese population. This registry seeks to fill that critical knowledge gap.
3. Primary and Secondary Objectives
The CN-IVI Registry is designed to answer several key questions:
Primary Objectives:
To determine the prevalence and natural distribution of calcified nodules in a large, real-world Chinese cohort of patients undergoing PCI with intravascular imaging guidance.
To establish the diagnostic criteria and imaging characteristics of CNs using both IVUS and/or OCT, creating a standardized definition for Chinese patients.
Secondary Objectives:
To evaluate the immediate procedural success rates of PCI for lesions containing CNs, as assessed by intravascular imaging (e.g., rate of stent underexpansion, acute stent malapposition).
To assess the impact of different calcium modification techniques (e.g., non-compliant balloons, scoring/cutting balloons, rotational/orbital atherectomy, intravascular lithotripsy) on the final stent result.
To investigate the long-term clinical outcomes for patients with CNs, including:
Target Lesion Failure (TLF): A composite of cardiac death, target vessel myocardial infarction, and clinically-driven target lesion revascularization (need for a repeat procedure).
Rates of stent thrombosis.
4. Study Design and Methodology
Type: Prospective, multi-center, observational registry.
Participants: Adult patients (≥18 years) undergoing coronary angiography and PCI for stable coronary artery disease or acute coronary syndromes at participating centers in China, in whom the use of IVUS or OCT is clinically indicated and identifies the presence of a calcified nodule.
Data Collection: All clinical, procedural, and imaging data will be collected prospectively in a centralized, secure electronic database. This includes:
Patient demographics and cardiovascular risk factors.
Angiographic data of the target lesion.
Raw IVUS and OCT imaging sequences, which will be analyzed in a dedicated core lab by independent experts blinded to patient outcomes to ensure consistency and objectivity.
Detailed procedural data, including devices used and complications.
Follow-up: Patients will be followed clinically for up to 3 years after the procedure through outpatient visits and telephone interviews to track their long-term health status and any cardiac-related events.
5. What Participation Means
For Patients: Participation in this registry does not change your standard medical care. The procedures (angiography, PCI, IVUS/OCT) are all performed based on your clinical need and your doctor's judgment. The registry simply involves allowing researchers to anonymously collect and analyze the data and images from your procedure for the purposes of this study. Your personal information will be kept strictly confidential. Your involvement will help advance medical knowledge and improve care for future patients with similar conditions.
For Families: This research aims to improve the safety and effectiveness of heart procedures for a particularly tricky problem. By supporting your family member's participation, you are contributing to a national effort to establish best practices that could benefit countless others.
For Healthcare Providers: This registry will provide invaluable, real-world evidence. It will offer deep insights into the imaging phenotypes of CNs, serve as a benchmark for procedural outcomes, and help generate data-driven guidelines for managing these complex lesions. The core lab analysis will also be an educational resource for the interventional cardiology community.
6. Potential Significance and Impact
The findings from the CN-IVI Registry are expected to have a direct impact on clinical practice:
Improved Diagnosis: Establish clear, imaging-based criteria for identifying CNs in Chinese patients.
Better Treatment Strategies: Provide evidence for which calcium modification techniques are most effective for preparing a nodule for stenting, leading to higher procedural success rates.
Enhanced Patient Safety: By optimizing stent implantation, the study aims to reduce long-term complications like stent failure and heart attacks, improving overall patient prognosis.
National Guidelines: The data will inform the development of Chinese and international clinical guidelines on the management of heavily calcified coronary lesions.
7. Ethics and Confidentiality
The study will be conducted in full compliance with the Declaration of Helsinki and Chinese regulatory requirements. The protocol will be approved by the Institutional Review Board (IRB) or Ethics Committee at each participating center. Written informed consent will be obtained from every patient before their data is included in the registry. All patient data will be de-identified to ensure absolute privacy and confidentiality.
In summary, the CN-IVI Registry represents a major collaborative effort to tackle a complex problem in interventional cardiology. By harnessing the power of intravascular imaging, it seeks to translate detailed visual data into tangible improvements in patient care and outcomes across China.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Coronary Artery Disease
Coronary Artery Atherosclerosis
Coronary Calcified Nodules
Coronary Calcification
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
COHORT
Study Time Perspective
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be at least 18 years old.
Intracoronary imaging confirms the presence of at least one calcified nodule lesion.
The patient is willing and able to comply with the study procedures and follow-up until the study concludes.
The subject confirms understanding of the study's risks, benefits, and alternative treatments, and has signed the informed consent form approved by the ethics committee prior to any protocol-related procedures.
Intracoronary imaging confirms the presence of at least one calcified nodule lesion.
The patient is willing and able to comply with the study procedures and follow-up until the study concludes.
The subject confirms understanding of the study's risks, benefits, and alternative treatments, and has signed the informed consent form approved by the ethics committee prior to any protocol-related procedures.
Exclusion Criteria
Contraindication to Procedure: Known contraindication to coronary angiography, PCI, or adjunctive pharmacologic therapy (e.g., aspirin, P2Y12 inhibitors, heparin, contrast media) that cannot be adequately managed with standard medical care.
Life Expectancy: Life expectancy of less than 1 year due to non-cardiac comorbid conditions (e.g., active malignancy, advanced organ failure).
Inability to Follow-Up: Inability or unwillingness to comply with the study protocol or scheduled follow-up visits.
Life Expectancy: Life expectancy of less than 1 year due to non-cardiac comorbid conditions (e.g., active malignancy, advanced organ failure).
Inability to Follow-Up: Inability or unwillingness to comply with the study protocol or scheduled follow-up visits.
Minimum Eligible Age
18 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Hospital of Jilin University
OTHER
Sponsor Role
collaborator
Zhongnan Hospital
OTHER
Sponsor Role
collaborator
Fu Wai Hospital, Beijing, China
OTHER
Sponsor Role
collaborator
Shanghai Zhongshan Hospital
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Zhang M, Matsumura M, Usui E, Noguchi M, Fujimura T, Fall KN, Zhang Z, Nazif TM, Parikh SA, Rabbani LE, Kirtane AJ, Collins MB, Leon MB, Moses JW, Karmpaliotis D, Ali ZA, Mintz GS, Maehara A. Intravascular Ultrasound-Derived Calcium Score to Predict Stent Expansion in Severely Calcified Lesions. Circ Cardiovasc Interv. 2021 Oct;14(10):e010296. doi: 10.1161/CIRCINTERVENTIONS.120.010296. Epub 2021 Oct 19.
Reference Type
BACKGROUND
Sato T, Yamamoto K, Matsumura M, Shlofmitz E, Khalique OK, Mintz GS, Shlofmitz RA, Jeremias A, Ali ZA, Maehara A. Discrimination of Calcified Nodule as a Cause of Coronary Angiographic Radiolucent Mass. JACC Cardiovasc Interv. 2023 Aug 14;16(15):1948-1949. doi: 10.1016/j.jcin.2023.04.013. Epub 2023 Jul 5. No abstract available.
Reference Type
BACKGROUND
Sato T, Matsumura M, Yamamoto K, Shlofmitz E, Moses JW, Khalique OK, Thomas SV, Tsoulios A, Cohen DJ, Mintz GS, Shlofmitz RA, Jeremias A, Ali ZA, Maehara A. Impact of Eruptive vs Noneruptive Calcified Nodule Morphology on Acute and Long-Term Outcomes After Stenting. JACC Cardiovasc Interv. 2023 May 8;16(9):1024-1035. doi: 10.1016/j.jcin.2023.03.009.
Reference Type
BACKGROUND
Hada M, Kakuta T, Sugiyama T, Hoshino M, Yonetsu T, Usui E, Hanyu Y, Nagamine T, Nogami K, Ueno H, Matsuda K, Sayama K, Setoguchi M, Tahara T, Sakamoto T, Mineo T, Kobayashi N, Takano M, Kondo S, Wakabayashi K, Suwa S, Dohi T, Mori H, Kimura S, Mitomo S, Nakamura S, Higuma T, Yamaguchi J, Natsumeda M, Ikari Y, Yamashita J, Mizukami T, Yamamoto MH, Sasano T, Shinke T; TACTICS Investigators. Prognostic Impact of Culprit Lesion Calcified Nodule After Emergency Coronary Intervention: A TACTICS Registry Subanalysis. JACC Cardiovasc Imaging. 2024 Nov;17(11):1384-1386. doi: 10.1016/j.jcmg.2024.06.010. Epub 2024 Aug 7. No abstract available.
Reference Type
BACKGROUND
Madhavan MV, Alsaloum M, Maehara A, Gogia S, Lee J, Fall K, Prasad M, McEntegart MB, Kirtane AJ. Recurrent Calcified Nodule Protrusion Through Stent Struts After Percutaneous Coronary Intervention of the RCA. JACC Cardiovasc Interv. 2023 Oct 9;16(19):2463-2465. doi: 10.1016/j.jcin.2023.07.033. Epub 2023 Sep 6. No abstract available.
Reference Type
BACKGROUND
Brott BC. The Calcified Nodule Paradox. JACC Cardiovasc Interv. 2023 May 8;16(9):1036-1038. doi: 10.1016/j.jcin.2023.04.001. No abstract available.
Reference Type
BACKGROUND
Shin D, Karimi Galougahi K, Spratt JC, Maehara A, Collet C, Barbato E, Ribichini FL, Gonzalo N, Sakai K, Mintz GS, Stone GW, Shlofmitz E, Shlofmitz RA, Jeremias A, Ali ZA. Calcified Nodule in Percutaneous Coronary Intervention: Therapeutic Challenges. JACC Cardiovasc Interv. 2024 May 27;17(10):1187-1199. doi: 10.1016/j.jcin.2024.03.032.
Reference Type
BACKGROUND
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CN-IVI Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Carotid Ultrasound Sub-Study of the Familial Atherosclerosis Study-observational Study
NCT00976014
COMPLETED
A Prospective, Single-site, Single-group Value Study on the Diagnosis of Functional Myocardial Ischemia Based on IVUS Plaque Characteristics
NCT07176585
COMPLETED
Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)
NCT05694065
ACTIVE_NOT_RECRUITING
Imaging and Physiologic Evaluation of Coronary Artery Disease
NCT05124249
RECRUITING
Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease
NCT04397211
ACTIVE_NOT_RECRUITING
NA
Intravascular Lithotripsy Versus Conventional Therapy for Severely Calcified Coronary Artery Lesions
NCT06238518
RECRUITING
NA
Beijing Percutaneous Coronary Intervention Registry
NCT01417325
UNKNOWN
Contemporary Clinical Treatment and Long-term Outcomes in Patient With Coronary Chronic Total Occlusion
NCT03614559
UNKNOWN
Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
NCT01353612
COMPLETED
Hemodynamic Change of Coronary Atherosclerotic Plaque After Evolocumab Treatment
NCT04416425
UNKNOWN
Clinical Implications of Three-vessel Ultrasonic Flow Ratio Measurement in Patients With Coronary Artery Disease
NCT06822894
RECRUITING
The Prognosis of Patients After PCI：a Multi-center Study in China
NCT05614050
RECRUITING
Peripheral Vascular Disease and Coronary Artery Disease
NCT03971864
COMPLETED
Association Between Carotid Plaque Length and Cardiovascular Events
NCT05159804
ACTIVE_NOT_RECRUITING
Study on the Improvement of Myocardial Microcirculation After Acute Anterior Myocardial Infarction
NCT06154395
RECRUITING
NA
Intravascular Ultrasound-derived Assessment of Hemodynamically Negative Lesions in NSTEACS Patients
NCT03641898
RECRUITING
IVUS-guided DES Implantation in Coronary Calcification
NCT05800002
RECRUITING
NA
Clinical Trial for Evaluating the Effectiveness and Safety of Online caIMR in STEMI Patients
NCT06118450
RECRUITING
Role of Intracoronary Imaging in Plaque Identification
NCT03953040
WITHDRAWN
Clinical Trial on the Treatment of Stent Underexpansion Caused by Calcification Using Intravascular Lithotripsy
NCT06521905
NOT_YET_RECRUITING
NA
Multicentre Registry of CCTA, IVUS and OCT
NCT04066062
ACTIVE_NOT_RECRUITING
Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques
NCT06855537
RECRUITING
PHASE4
IVUS Assessment of Atheroma Burden After Acute Coronary Syndrome
NCT01578005
COMPLETED
A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis
NCT07034157
RECRUITING
Risk Factors Promoting Coronary Plaque Progression In China
NCT02692014
UNKNOWN